Advertisement
UK markets close in 5 hours 6 minutes

  • FTSE 100

    8,112.30
    +33.44 (+0.41%)
     

  • FTSE 250

    19,824.96
    +222.98 (+1.14%)
     

  • AIM

    756.07
    +2.95 (+0.39%)
     

  • GBP/EUR

    1.1661
    +0.0005 (+0.04%)
     

  • GBP/USD

    1.2518
    +0.0007 (+0.06%)
     

  • Bitcoin GBP

    51,467.99
    +656.29 (+1.29%)
     

  • CMC Crypto 200

    1,392.89
    -3.64 (-0.26%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    83.87
    +0.30 (+0.36%)
     

  • GOLD FUTURES

    2,360.20
    +17.70 (+0.76%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,049.12
    +131.84 (+0.74%)
     

  • CAC 40

    8,038.84
    +22.19 (+0.28%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Company News for Sep 30, 2021

Zacks Equity Research
·1-min read

  • Cintas Corporation’s CTAS shares rose 0.8% after the company reported first-quarter of fiscal 2022 earnings of $3.11 per share, surpassing the Zacks Consensus Estimate of $2.76.

  • Shares of NuCana plc NCNA surged 17.3% after the company reported that the FDA granted Fast Track designation to its Acelarin (NUC-1031) for the first-line treatment of patients with advanced biliary tract cancer.

  • GeoVax Labs, Inc.’s GOVX shares jumped 8.7% after the company reported the purchase of exclusive rights to PNP Therapeutics' development and commercialization of Gedeptin.

  • Shares of Lucid Group, Inc. LCID surged 7.1% after it kicked off production of its electric vehicles in Casa Grande, Arizona and reported that deliveries would begin in late October.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cintas Corporation (CTAS) : Free Stock Analysis Report
 
GeoVax Labs Inc. (GOVX): Free Stock Analysis Report
 
NuCana PLC Sponsored ADR (NCNA) : Free Stock Analysis Report
 
Lucid Group, Inc. (LCID) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.